PL
PL · PL · PL-100468599
Nucala
ATC R03DX09
Last synced from URPL (Poland) on
Identification
ManufacturerGlaxoSmithKline Trading Services Limited
CountryPL (PL)
ATC codeR03DX09
Dispensing—
ReimbursedNo
SourceURPL (Poland)
Last synced6/14/2026
Packs · 2
- gtin05909991483296
- gtin05909991483302
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Roztwór do wstrzykiwań w ampułko-strzykawce",
"source": "urpl",
"strength": "40 mg",
"packaging": "05909991483296 ¦ Rpz ¦ EU/1/15/1043/010 ¦ 144991\n3 amp.-strzyk. 0,4 ml\n05909991483302 ¦ Rpz ¦ EU/1/15/1043/009 ¦ 144992\n1 amp.-strzyk. 0,4 ml",
"substance": "Mepolizumabum 40 mg",
"common_name": "Mepolizumabum",
"pl_product_id": "100468599",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}Related drugs
Other records sharing ATC code R03DX09.
- 🇨🇭NucalaGlaxoSmithKline AG
- ISNucalaGlaxoSmithKline Trading Services Limited
- ISNucalaGlaxoSmithKline Trading Services Limited
- 🇨🇭NucalaGlaxoSmithKline AG
- 🇺🇸NucalaGlaxoSmithKline LLC
- PLNucalaGlaxoSmithKline Trading Services Limited
- PLNucalaGlaxoSmithKline Trading Services Limited
- DKNucalaGlaxoSmithKline Trading Services
Access this data programmatically
Query Nucala and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.